molybdenum disulfide has been researched along with 2019 Novel Coronavirus Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, Q; Liu, W; Wang, C; Wang, S; Xin, Y | 1 |
| Benz, M; Levkin, PA; Oudeng, G; Popova, AA; Yang, M; Yi, C; Zhang, Y | 1 |
| Jaiswal, A; Kumar, P; Roy, S; Sarkar, A | 1 |
3 other study(ies) available for molybdenum disulfide and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Core-shell nanocomposite of flower-like molybdenum disulfide nanospheres and molecularly imprinted polymers for electrochemical detection of anti COVID-19 drug favipiravir in biological samples.
Topics: Amides; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Disulfides; Electrochemical Techniques; Humans; Limit of Detection; Molecularly Imprinted Polymers; Molybdenum; Nanocomposites; Nanospheres; Oxidation-Reduction; Pyrazines; Reproducibility of Results; SARS-CoV-2 | 2022 |
Droplet Microarray Based on Nanosensing Probe Patterns for Simultaneous Detection of Multiple HIV Retroviral Nucleic Acids.
Topics: Biosensing Techniques; COVID-19; Disulfides; Fluorescence; Fluorescence Resonance Energy Transfer; HIV; HIV Infections; Humans; Molybdenum; Nanostructures; Nucleic Acids; SARS-CoV-2 | 2020 |
Reusable MoS
Topics: Anti-Infective Agents; COVID-19; Disulfides; Escherichia coli; Glutathione; Humans; Molybdenum; Nanostructures; Oxidation-Reduction; Particle Size; Personal Protective Equipment; Reactive Oxygen Species; Recycling; SARS-CoV-2; Staphylococcus aureus; Sunlight; Temperature | 2021 |